IRB Study Number 22-166
Status Recruiting
Phase Not Applicable
Location Cleveland Clinic Main Campus
Institute Heart and Vascular Institute
Description
The Cordio HearO™ is a software medical device that remotely monitors CHF patients by detecting changes in the patients' recorded voice relative to a baseline. It is a simple voice test with the potential to alert on fluid retention in the lungs and thereby help identify the onset of heart failure to reduce patient deterioration and prevent hospitalizations. This study will assess the ability of the Cordio App to detect patient deterioration based on vocal parameters thus providing effective technology-based home monitoring for HF patients. Participants will use the Cordio App daily.
Inclusion Criteria
1) Age 22 or older
2) Male or non-pregnant female
3) Diagnosed with symptomatic Chronic Heart Failure
Exclusion Criteria
1) Unable to read English
2) Unable to comply with daily use of Cordio App
3) Life expectancy of less than 12 months
